Avience Biomedicals Limited (NSE: AVIENCE), ISIN INE0V9I01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AVIENCE last traded at ₹306.20 (-5.00%), with a 52-week range of ₹395.20 to ₹414.95 (as of 6 Jul 2026).
Data sourced from NSE and BSE filings. Educational — not investment advice.